相关实验视频

Updated: Sep 11, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

遗传变化影响非小细胞肺癌的免疫背景:乌克兰研究

Denys Kozakov^1,2, Nazarii Kobyliak^1,3, Sofiia Livshun¹

¹Medical Laboratory CSD, Kyiv, Ukraine.

Frontiers in medicine

|August 14, 2025

概括

非小细胞肺癌 (NSCLC) 的遗传变化会影响免疫治疗反应. 这项研究将瘤驱动突变 (EGFR,ALK,KRAS) 与不同的瘤免疫微环境 (TME) 和PD-L1表达联系起来,指导个性化治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
遗传学遗传学是一种遗传学.

背景情况:

在非小细胞肺癌 (NSCLC) 中,基因改变和瘤免疫微环境 (TME) 之间的相互作用对于免疫疗法反应至关重要,但仍然不完全理解.
了解这些关系可以帮助为NSCLC患者量身定制治疗策略.

研究的目的:

研究瘤驱动突变与NSCLC的免疫背景之间的关联.
探索特定基因变异 (EGFR,ALK,KRAS) 对PD-L1表达,免疫细胞透 (CD8+,CD163+) 和TME分类 (免疫沙漠,排除,炎症) 的影响.

主要方法:

一项对254例NSCLC病例 (LUAD和SCC) 的队列研究,具有下一代测序 (NGS) 和病理学数据.
对基因变异,PD-L1表达和CD8+T细胞和CD163+巨细胞的透进行分析.
基于癌症免疫周期的TME的分类.

主要成果:

超过一半的NSCLC病例 (52%) 患有瘤驱动因子改变,EGFR (18.5%) 和ALK (9.4%) 改变的比例很高.
EGFR和ALK的改变与高PD-L1表达和独特的免疫特征有关.
EGFR突变的LUAD主要表现出免疫沙漠TME,而ALK重组和KRAS突变的NSCLC表现出免疫排除的TME. 非瘤基因成的NSCLC显示了一个炎症的TME.

结论:

在NSCLC中特定的瘤驱动突变与独特的免疫逃避机制和TME表型相关.
EGFR和ALK变化与高PD-L1表达有关,但免疫性和TME类型各不相同.
对这些机制的进一步研究对于优化NSCLC免疫疗法选择和患者管理至关重要.

关键词:

腺癌瘤是一种腺癌.癌症免疫循环癌症免疫循环遗传变化遗传变化免疫环境的背景非小细胞肺癌的肺癌.瘤基因的基因基因.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...